Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Cardiometabolic health among gastric bypass surgery patients with polycystic ovarian syndrome.

Gomez-Meade CA, Lopez-Mitnik G, Messiah SE, Arheart KL, Carrillo A, de la Cruz-Muñoz N.

World J Diabetes. 2013 Jun 15;4(3):64-9. doi: 10.4239/wjd.v4.i3.64.

2.

Reduction in cardiometabolic disease risk following gastric bypass surgery among Hispanic adults.

De La Cruz-Muñoz N, Lopez-Mitnik G, Arheart KL, Livingstone AS, Miller TL, Lipshultz SE, Messiah SE.

Metab Syndr Relat Disord. 2013 Aug;11(4):262-6. doi: 10.1089/met.2012.0172. Epub 2013 Apr 23.

PMID:
23611341
3.

Effect of ethnicity on weight loss after bariatric surgery.

Khorgami Z, Arheart KL, Zhang C, Messiah SE, de la Cruz-Muñoz N.

Obes Surg. 2015 May;25(5):769-76. doi: 10.1007/s11695-014-1474-9.

PMID:
25430619
4.

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.

Legro RS, Kunselman AR, Dunaif A.

Am J Med. 2001 Dec 1;111(8):607-13.

PMID:
11755503
5.

Ethnic differences in the ability of triglyceride levels to identify insulin resistance.

Sumner AE, Cowie CC.

Atherosclerosis. 2008 Feb;196(2):696-703. Epub 2007 Jan 24.

PMID:
17254586
6.

Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial.

Risstad H, Søvik TT, Engström M, Aasheim ET, Fagerland MW, Olsén MF, Kristinsson JA, le Roux CW, Bøhmer T, Birkeland KI, Mala T, Olbers T.

JAMA Surg. 2015 Apr;150(4):352-61. doi: 10.1001/jamasurg.2014.3579.

PMID:
25650964
7.

Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.

Sam S, Scoccia B, Yalamanchi S, Mazzone T.

Hum Reprod. 2015 Jun;30(6):1358-64. doi: 10.1093/humrep/dev073. Epub 2015 Apr 8.

8.

Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial.

Søvik TT, Aasheim ET, Taha O, Engström M, Fagerland MW, Björkman S, Kristinsson J, Birkeland KI, Mala T, Olbers T.

Ann Intern Med. 2011 Sep 6;155(5):281-91. doi: 10.7326/0003-4819-155-5-201109060-00005.

PMID:
21893621
9.

Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.

Halperin F, Ding SA, Simonson DC, Panosian J, Goebel-Fabbri A, Wewalka M, Hamdy O, Abrahamson M, Clancy K, Foster K, Lautz D, Vernon A, Goldfine AB.

JAMA Surg. 2014 Jul;149(7):716-26. doi: 10.1001/jamasurg.2014.514.

10.

Changes in hormones and biomarkers in polycystic ovarian syndrome treated with gastric bypass.

Eid GM, McCloskey C, Titchner R, Korytkowski M, Gross D, Grabowski C, Wilson M.

Surg Obes Relat Dis. 2014 Sep-Oct;10(5):787-91. doi: 10.1016/j.soard.2014.02.046. Epub 2014 Mar 15.

PMID:
25066098
11.

Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass.

Eid GM, Cottam DR, Velcu LM, Mattar SG, Korytkowski MT, Gosman G, Hindi P, Schauer PR.

Surg Obes Relat Dis. 2005 Mar-Apr;1(2):77-80.

PMID:
16925218
12.

Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6-year analysis of data.

Jamal M, Wegner R, Heitshusen D, Liao J, Samuel I.

Surg Obes Relat Dis. 2011 Jul-Aug;7(4):473-9. doi: 10.1016/j.soard.2010.08.009. Epub 2010 Aug 26.

PMID:
21036105
13.

Metabolic Changes After Roux-N-Y Bariatric Surgery In Hispanics.

Hernández-Gil de Lamadrid J, Nieves-Rivera JJ, Mora L, Corretjer L, Altieri PI, Suárez A, Banchs HL, Muñiz J, Soto MI, Escobales N, Crespo M.

Bol Asoc Med P R. 2015 Jul-Sep;107(3):66-9.

PMID:
26742199
14.

Impact of restrictive (sleeve gastrectomy) vs hybrid bariatric surgery (Roux-en-Y gastric bypass) on lipid profile.

Benaiges D, Flores-Le-Roux JA, Pedro-Botet J, Ramon JM, Parri A, Villatoro M, Carrera MJ, Pera M, Sagarra E, Grande L, Goday A; Obemar Group.

Obes Surg. 2012 Aug;22(8):1268-75. doi: 10.1007/s11695-012-0662-8.

PMID:
22544352
15.

Metabolic syndrome is less likely to resolve in Hispanics and non-Hispanic blacks after bariatric surgery.

Coleman KJ, Huang YC, Koebnick C, Reynolds K, Xiang AH, Black MH, Alskaf S.

Ann Surg. 2014 Feb;259(2):279-85. doi: 10.1097/SLA.0000000000000258.

PMID:
24100336
16.

Clustering of cardiometabolic risk factors and risk of elevated HbA1c in non-Hispanic White, non-Hispanic Black and Mexican-American adults with type 2 diabetes.

Okosun IS, Annor F, Dawodu EA, Eriksen MP.

Diabetes Metab Syndr. 2014 Apr-Jun;8(2):75-81. doi: 10.1016/j.dsx.2014.04.026. Epub 2014 May 18.

PMID:
24907170
17.

Roux-en-Y Gastric Bypass Surgery in Patients with Polycystic Ovary Syndrome and Metabolic Syndrome.

Turkmen S, Ahangari A, Bäckstrom T.

Obes Surg. 2016 Jan;26(1):111-8. doi: 10.1007/s11695-015-1729-0.

PMID:
25975201
18.

Effects of obesity surgery on the metabolic syndrome.

Lee WJ, Huang MT, Wang W, Lin CM, Chen TC, Lai IR.

Arch Surg. 2004 Oct;139(10):1088-92.

PMID:
15492149
19.

Bariatric surgery: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(1):1-148. Epub 2005 Jan 1.

20.

Roux-en-Y gastric bypass ameliorates polycystic ovary syndrome and dramatically improves conception rates: a 9-year analysis.

Jamal M, Gunay Y, Capper A, Eid A, Heitshusen D, Samuel I.

Surg Obes Relat Dis. 2012 Jul-Aug;8(4):440-4. doi: 10.1016/j.soard.2011.09.022. Epub 2011 Oct 6.

PMID:
22169760

Supplemental Content

Support Center